A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Another unsettled day with cloud, rain and blustery winds.
Buried here are the men of the 10th West Yorks, the unit that suffered the heaviest losses on the first day of the Somme.